2012
DOI: 10.1128/cvi.00096-12
|View full text |Cite
|
Sign up to set email alerts
|

Migration of the Swine Influenza Virus δ-Cluster Hemagglutinin N-Linked Glycosylation Site from N142 to N144 Results in Loss of Antibody Cross-Reactivity

Abstract: Routine antigenic characterization of swine influenza virus isolates in a high-throughput serum neutralization (HTSN) assay found that approximately 20% of isolates were not neutralized by a panel of reference antisera. Genetic analysis revealed that nearly all of the neutralization-resistant isolates possessed a seasonal human-lineage hemagglutinin (HA; ␦ cluster). Subsequent sequencing analysis of full-length HA identified a conserved N144 residue present only in neutralization-resistant strains. N144 lies i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 30 publications
0
8
0
Order By: Relevance
“…The Chile/83 virus has a glycosylation site at residue 144 on its HA, along with the K147 residue (3). H1N1 swine isolates with an N-linked glycosylation site at residue 144 render these influenza viruses resistant to antibody-meditated neutralization, whereas viruses with an N142 residue instead of an N144 residue are sensitive to neutralization (19). Therefore, even if the glycan is missing on the HA immunogens and the putative neutralizing epitope is exposed to elicit high-titer antibodies to this specific epitope, if the epitope is shielded on the target HA antigen, the effectiveness of the vaccine to protect against influenza infection is decreased.…”
Section: Fig 12mentioning
confidence: 99%
“…The Chile/83 virus has a glycosylation site at residue 144 on its HA, along with the K147 residue (3). H1N1 swine isolates with an N-linked glycosylation site at residue 144 render these influenza viruses resistant to antibody-meditated neutralization, whereas viruses with an N142 residue instead of an N144 residue are sensitive to neutralization (19). Therefore, even if the glycan is missing on the HA immunogens and the putative neutralizing epitope is exposed to elicit high-titer antibodies to this specific epitope, if the epitope is shielded on the target HA antigen, the effectiveness of the vaccine to protect against influenza infection is decreased.…”
Section: Fig 12mentioning
confidence: 99%
“…Surprisingly, swANP32A showed mild ability to support polymerase activities of H7N9 ZJ13 and H9N2 ZJ12 (Fig 1A and 1B). Mammalian ANP32 proteins showed the support ability to the replication of mammalian influenza A viruses, including human influenza virus A/WSN/1933 (WSN) [56] (Fig 1C), swine influenza virus A/swine/North Carolina/3793/08 (H1N1 NC08 ) [57] (Fig 1D), H3N2 canine influenza virus A/canine/Guangdong/1/2011 (H3N2 GD12 ) [58] (Fig 1E), and A/equine/Xinjiang/1/2007 (H3N8 XJ07 ) [59] (Fig 1F). In addition, we noticed that some mammalian influenza viruses had lower activity in the presence of caANP32B than with caANP32A ( Fig 1).…”
Section: Avian Influenza Virus Polymerase Activity Is Stronger In Thementioning
confidence: 99%
“…RVC VP7 model has an increased surface area with highly probable antigenic properties suggesting that there might be a correlation between the degree of accessible antigenic regions and the number of N-linked glycosylation sites. Indeed, as has been suggested for HIV, glycosylation sites provide variability that allows the virus to escape immune detection of nearby conserved amino acids at the receptor-binding site and modulate antigenicity (76, 77). Further supporting this, in RV it has been possible to select monoclonal neutralization escape mutants that have new glycosylation sites in a defined epitope (78).…”
Section: Discussionmentioning
confidence: 99%